Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
J Paediatr Child Health ; 57(12): 1976-1980, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34169605

ABSTRACT

AIM: The objective of this study was to describe clinical features and to assess the risk factors associated with mortality in Pseudomonas aeruginosa bacteraemia in a tertiary Japanese paediatric care hospital. METHODS: Patients diagnosed with P. aeruginosa bacteraemia at our hospital between 2007 and 2018 were analysed in a retrospective case series. Inadequate initial therapy for P. aeruginosa bacteraemia was defined as initial treatment without antipseudomonal antibiotics or an administration of antipseudomonal agent to which the causative strain was resistant. Bacteraemia-related death was defined as all deaths occurring within 7 days after the onset of bacteraemia. RESULTS: Overall, 41 patients with 42 P. aeruginosa bacteraemia episodes were identified. The most common underlying condition was malignancy (27%), followed by congenital heart disease (20%) and preterm birth (17%). Among the 42 P. aeruginosa clinical isolates, 24% were resistant to at least one of the antipseudomonal agents and 10% were resistant to more than one agent. The susceptibility levels for piperacillin, fourth-generation cephalosporins and ciprofloxacin were higher than that for carbapenems. Bacteraemia-related death was observed in 43% of episodes. The 30-day all-cause mortality was 50% (standard error 8%). Neonates, intensive care, mechanical ventilation, afebrile episodes, septic shock, hypoxia, renal injury and inadequate initial therapy were associated with bacteraemia-related death episodes. CONCLUSIONS: We found that childhood P. aeruginosa bacteraemia is still a high mortality disease. Our results imply the importance of the identification of high-risk patients and the establishment of adequate empirical antibiotic therapy.


Subject(s)
Bacteremia , Premature Birth , Pseudomonas Infections , Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Child , Humans , Infant, Newborn , Pseudomonas Infections/drug therapy , Pseudomonas aeruginosa , Retrospective Studies , Risk Factors
2.
J Neurochem ; 157(4): 1167-1181, 2021 05.
Article in English | MEDLINE | ID: mdl-33025585

ABSTRACT

Heterotrimeric G-proteins are composed of α, ß, and γ subunits, and function as signal transducers. Critical roles of the α-subunits of Gi/o family heterotrimeric G-proteins, Gαi2, and Gαo1, have so far been reported in brain development and neurodevelopmental disorders. In this study, we tried to clarify the role of Gαi1, α-subunit of another Gi/o family member Gi1, during corticogenesis, based on the recent identification of its gene abnormalities in neurodevelopmental disorders. In western blot analyses, Gαi1 was found to be expressed in mouse brain in a developmental stage-dependent manner. Morphological analyses revealed that Gαi1 was broadly distributed in cerebral cortex with relatively high expression in the ventricular zone (VZ) at embryonic day (E) 14. Meanwhile, Gαi1 was enriched in membrane area of yet unidentified early mitotic cells in the VZ and the marginal zone at E14. Acute knockdown of Gαi1 with in utero electroporation in cerebral cortex caused cell cycle elongation of the neural progenitor cells and promoted their cell cycle exit. Gαi1-deficient cortical neurons also exhibited delayed radial migration during corticogenesis, with abnormally elongated leading processes and hampered nucleokinesis. In addition, silencing of Gαi1 prevented basal dendrite development. The migration and dendritic phenotypes were at least partially rescued by an RNAi-resistant version of Gαi1. Collectively, these results strongly suggest a crucial role of Gi1 in cortical development, and disturbance of its function may cause deficits in synaptic network formation, leading to neurodevelopmental disorders.


Subject(s)
Cerebral Cortex/metabolism , Heterotrimeric GTP-Binding Proteins/metabolism , Neural Stem Cells/metabolism , Neurogenesis/physiology , Animals , Cell Movement/physiology , Cell Proliferation/physiology , Dendrites/metabolism , Mice , Mice, Inbred ICR , Neurons/metabolism
3.
Dev Neurosci ; 41(1-2): 139-148, 2019.
Article in English | MEDLINE | ID: mdl-31430754

ABSTRACT

POGZ is a heterochromatin protein 1 α-binding protein and regulates gene expression. On the other hand, accumulating pieces of evidence indicate that the POGZ gene abnormalities are involved in various neurodevelopmental disorders. In this study, we prepared a specific antibody against POGZ, anti-POGZ, and carried out biochemical and morphological characterization with mouse brain tissues. Western blotting analyses revealed that POGZ is expressed strongly at embryonic day 13 and then gradually decreased throughout the brain development process. In immunohistochemical analyses, POGZ was found to be enriched in cerebrocortical and hippocampal neurons in the early developmental stage. The nuclear expression was also detected in Purkinje cells in cerebellum at postnatal day (P)7 and P15 but disappeared at P30. In primary cultured hippocampal neurons, while POGZ was distributed mainly in the nucleus, it was also visualized in axon and dendrites with partial localization at synapses in consistency with the results obtained in biochemical fractionation analyses. The obtained results suggest that POGZ takes part in the regulation of synaptic function as well as gene expression during brain development.


Subject(s)
Brain/metabolism , Neurogenesis/physiology , Transposases/metabolism , Animals , Brain/embryology , Brain/growth & development , Gene Expression Regulation, Developmental/physiology , Mice , Neurodevelopmental Disorders/genetics , Neurodevelopmental Disorders/metabolism
4.
World J Pediatr ; 15(3): 270-275, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31011987

ABSTRACT

BACKGROUND: There is limited information concerning the overall epidemiology of invasive fungal disease (IFD) in children. The aim of this study was to clarify the clinical features of IFD in a tertiary pediatric care hospital. METHODS: Patients diagnosed with proven or probable IFD at our hospital between 2011 and 2015 were retrospectively reviewed. Proven and probable IFD were defined according to the European Organization for Research and Treatment of Cancer/Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group consensus. Patients with possible IFD were excluded. RESULTS: The incidence of proven or probable IFD was 26 of 20,079 hospitalized patients (0.13%). The predominant underlying disease was malignancy (54%) and congenital anomaly (27%). The most common diagnosis was candidemia among the patients with proven IFD (8 of 13, 62%). All the isolated pathogens in the candidemia patients were non-albicans Candida spp. The most common site of infection was the lungs in patients with probable IFD (11 of 13 patients, 85%). In probable IFD episodes, positive ß-D-glucan and galactomannan were found in 12 of 13 (92%) and 5 of 13 (38%) patients, respectively. All but one patient (96%) received empirical antifungal therapy. No patients underwent surgical resection of residual lesions. The overall mortality was 23% and the attributable mortality of IFD was 12%. CONCLUSION: Our results suggest the emergence of non-albicans Candida species as important pathogens in childhood IFD.


Subject(s)
Invasive Fungal Infections/epidemiology , Invasive Fungal Infections/microbiology , Adolescent , Child , Child, Hospitalized , Child, Preschool , Female , Humans , Incidence , Infant , Invasive Fungal Infections/mortality , Japan/epidemiology , Male
5.
Dev Neurosci ; 40(3): 278-287, 2018.
Article in English | MEDLINE | ID: mdl-30227424

ABSTRACT

MACRO Domain Containing 2 (MacroD2) is a neurodevelopmental disorder-related mono-ADP-ribosylhydrolase. Molecular features of this protein in neural tissues are largely unknown. In this study, we generated a specific antibody against MacroD2, and carried out expression and morphological analyses of the molecule during mouse brain development. In Western blotting, 2 MacroD2 isoforms with molecular masses of ∼70 and ∼75 kDa started to be expressed at embryonic day 16.5, reached the maximal level at postnatal day 8, and then gradually decreased through P30. In contrast, other isoforms with molecular masses of ∼110 and ∼140 kDa gradually increased during embryonic to postnatal development. In immunohistochemical analyses, MacroD2 was strongly detected in cortical neurons in layer II-V at P0 and P7, while the protein expression decreased significantly in the neurons at P30. Immunofluorescence analyses revealed that MacroD2 was mainly distributed in the soma and to a lesser extent in the axon and dendrite of immature primary cultured mouse hippocampal neurons. On the other hand, in the matured hippocampal neurons, while MacroD2 was detected in the soma, it displayed in dendrites a punctate distribution pattern with a partial colocalization with synaptic markers, synaptophysin, and PSD95. The obtained results indicate that MacroD2 is expressed and may have a physiological role in the central nervous system during brain development.


Subject(s)
DNA Repair Enzymes/metabolism , Hippocampus/pathology , Hydrolases/metabolism , N-Glycosyl Hydrolases/metabolism , Neurons/metabolism , Animals , Axons/metabolism , Cells, Cultured , Dendrites/metabolism , Disks Large Homolog 4 Protein/metabolism , Hippocampus/metabolism , Mice , Neurogenesis/physiology , Synaptophysin/metabolism
6.
Neuropathology ; 34(1): 49-57, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23711246

ABSTRACT

Niemann-Pick disease type C (NPC) is an autosomal recessive neurovisceral lipid storage disorder. Two disease-causing genes (NPC1 and NPC2) have been identified. NPC is characterized by neuronal and glial lipid storage and NFTs. Here, we report a man with juvenile-onset progressive neurological deficits, including pyramidal signs, ataxia, bulbar palsy, vertical supranuclear ophthalmoplegia, and psychiatric symptoms; death occurred at age 37 before definitive clinical diagnosis. Post mortem gross examination revealed a unique distribution of brain atrophy, predominantly in the frontal and temporal lobes. Microscopically, lipid storage in neurons and widely distributed NFTs were observed. Lipid storage cells appeared in systemic organs and filipin staining indicated intracellular cholesterol accumulation in hepatic macrophages. Electron microscopy revealed accumulation of lipids and characteristic oligolamellar inclusions. These findings suggested an NPC diagnosis. Neuronal loss and gliosis were frequently accompanied by NFTs and occurred in the frontal and temporal cortices, hippocampus, amygdala, basal forebrain, basal ganglia, thalamus, substantia nigra and brain stem nuclei. Lewy bodies (LBs) were observed in most, but not all, regions where NFTs were evident. In contrast, neuronal lipid storage occurred in more widespread areas, including the parietal and occipital cortices where neurodegeneration with either NFTs or LBs was minimal. Molecular genetic analysis demonstrated that the patient had compound heterozygous mutations in the cysteine-rich loop (A1017T and Y1088C) of the NPC1 gene. To our knowledge there has been no previous report of the A1017T mutation. The pathological features of this patient support the notion that NPC has an aspect of α-synucleinopathy, and long-term survivors of NPC may develop a frontotemporal-predominant distribution of brain atrophy.


Subject(s)
Niemann-Pick Disease, Type C/pathology , Adult , Brain Stem/pathology , Carrier Proteins/genetics , Cerebral Cortex/pathology , Frontal Lobe/pathology , Humans , Intracellular Signaling Peptides and Proteins , Lewy Bodies/pathology , Male , Membrane Glycoproteins/genetics , Mutation , Neurofibrillary Tangles/pathology , Niemann-Pick C1 Protein , Niemann-Pick Disease, Type C/diagnosis , Niemann-Pick Disease, Type C/genetics , Temporal Lobe/pathology
7.
Article in English | MEDLINE | ID: mdl-23528866

ABSTRACT

Excitotoxicity is involved in neurodegenerative conditions. We investigated the pathological significance of a surge in prostaglandin production immediately after kainic acid (KA) administration [initial phase], followed by a sustained moderate elevation in prostaglandin level [late phase] in the hippocampus of juvenile rats. Numerous pyknotic hippocampal neurons were observed 72 h after KA treatment; this number remained elevated on days 10 and 30. Gross hippocampal atrophy was observed on days 10 and 30. Pre-treatment with indomethacin ameliorated neuronal death on days 10 and 30, and prevented hippocampal atrophy on day 30. Microglial response was moderated by the indomethacin pre-treatment. Blockade of only late-phase prostaglandin production by post-treatment with indomethacin ameliorated neuronal death on day 30. These findings suggest a role for initial-phase prostaglandin production in chronic progressive neuronal death, which is exacerbated by late-phase prostaglandin production. Blockade of prostaglandin production has therapeutic implications in preventing long-term neurological sequelae following excitotoxic brain damage.


Subject(s)
Hippocampus/metabolism , Kainic Acid/toxicity , Prostaglandins/biosynthesis , Animals , Cell Death , Hippocampus/drug effects , Hippocampus/pathology , Male , Microglia/drug effects , Microglia/metabolism , Microglia/pathology , Nerve Degeneration/pathology , Neurons/drug effects , Neurons/metabolism , Neurons/pathology , Rats , Rats, Wistar
8.
Exp Dermatol ; 22(1): 62-4, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23278896

ABSTRACT

Skin photoageing is a complex, multifactorial process and both intrinsic and extrinsic factors may contribute to its pathogenesis. The ultraviolet-irradiated hairless mouse has been used as an animal model for photoageing, but this model mimics only the 'extrinsic' aspects. Here, we show that skin from old SAMP1 mice, a model for higher oxidative stress and senescence acceleration, exhibited histological and gene expression changes similar to those in human photoaged skin without ultraviolet irradiation. These changes include an increase in elastic fibre and glycosaminoglycan histologically, an upregulation of several proinflammatory cytokines and matrix metalloproteinases, and an increase in lipid peroxide. We propose that SAMP1 mice are a spontaneous animal model for photoageing caused by an exaggerated intrinsic mechanism, namely, higher oxidative status. This mouse model is useful to explore the link between oxidative stress and photoageing, and to evaluate the efficacy of antioxidants.


Subject(s)
Oxidative Stress , Skin Aging/genetics , Skin Aging/pathology , Animals , Gene Expression , Interferon-gamma/genetics , Interleukin-1beta/genetics , Interleukin-6/genetics , Matrix Metalloproteinase 12/genetics , Matrix Metalloproteinase 7/genetics , Mice , Models, Animal , Nitric Oxide Synthase Type II/genetics , Phenotype , RNA, Messenger/metabolism , Skin Aging/physiology , Thiobarbituric Acid Reactive Substances/metabolism , Transforming Growth Factor beta1/genetics , Tumor Necrosis Factor-alpha/genetics
9.
Brain Behav Immun ; 29: 82-97, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23270678

ABSTRACT

Although the immune system modulates higher functions of the brain under non-inflammatory conditions, how immune cells interact with brain parenchymal cells remains to be determined. Using bone marrow chimeric mice in which the recipients' immune system was reconstituted by marrow cells derived from GFP-transgenic mice by syngeneic intra-bone marrow-bone marrow transplantation (IBM-BMT) and by intravenous (IV)-BMT, we examined the distribution, density and differentiation of donor-derived marrow cells in the brain parenchyma 2 weeks and 1, 4 and 8 months after BMT. Marrow-derived cells started to populate discrete brain regions from 1 to 4 months after BMT, exhibited ramified morphology and expressed Iba-1. The ramified marrow-derived cells were distributed in more brain regions and for a longer time after IBM-BMT than IV-BMT. Most of these discrete regions were adjacent to the attachments of choroid plexus that comprised thinned brain parenchyma consisting of astroglial processes in the narrow channel between the ependyma and pia. These specific portions of astroglial processes expressed fractalkine. In the choroid plexus stroma, not only Iba-1+ myeloid cells but also non-myeloid CXCL12-expressing cells were of bone marrow-origin. Transcripts of fractalkine, CXCL12 and their related molecules such as CX3CR1, ADAM10 and CXCR4 were detected in the tissue consisting of the choroid plexus, the attachments and adjacent brain parenchyma. Thus, bone marrow cells selectively enter the discrete brain regions adjacent to the attachments of choroid plexus and differentiate into ramified myeloid cells. Fractalkine in the attachments of choroid plexus and CXCL12 in the choroid plexus stroma may be involved in these brain-immune interactions.


Subject(s)
Bone Marrow Cells/physiology , Brain/cytology , Choroid Plexus/cytology , Animals , Bone Marrow Transplantation/immunology , Calcium-Binding Proteins/biosynthesis , Cell Differentiation , Cell Separation , Chemokine CX3CL1/biosynthesis , Chemokine CX3CL1/genetics , Chemokine CXCL12/biosynthesis , Green Fluorescent Proteins , Immunohistochemistry , Male , Meninges/cytology , Mice , Mice, Inbred C57BL , Microfilament Proteins/biosynthesis , Myeloid Cells/physiology , RNA/biosynthesis , RNA/isolation & purification , Real-Time Polymerase Chain Reaction , Signal Transduction/genetics , Signal Transduction/physiology
10.
Neurobiol Dis ; 43(3): 706-14, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21669285

ABSTRACT

Excitotoxicity is involved in seizure-induced acute neuronal death, hypoxic-ischemic encephalopathy, and chronic neurodegenerative conditions such as Alzheimer's disease. Although oxidative stress has been implicated in excitotoxicity, the target proteins of oxidative damage during the course of excitotoxic cell death are still unclear. In the present study, we performed 2D-oxyblot analysis and mass spectrometric amino acid sequencing to identify proteins that were vulnerable to oxidative damage in the rat hippocampus during kainic acid (KA)-induced status epilepticus. We first investigated the time course in which oxidative protein damage occurred using immunohistochemistry. Carbonylated proteins, a manifestation of protein oxidation, were detected in hippocampal neurons as early as 3h after KA administration. Immunoreactivity for 8-hydroxy-2'-deoxyguanosine (8-OHdG) was also elevated at the same time point. The increase in oxidative damage to proteins and DNA occurred concomitantly with the early morphological changes in KA-treated rat hippocampus, i.e., changes in chromatin distribution and swelling of rough endoplasmic reticulum and mitochondria, which preceded the appearance of morphological features of neuronal death such as pyknotic nuclei and hypereosinophilic cytoplasm. Proteomic analysis revealed that several hippocampal proteins were consistently carbonylated at this time point, including heat shock 70kDa protein 4, valosin-containing protein, mitochondrial inner membrane protein (mitofilin), α-internexin, and tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein (14-3-3 protein). We propose that oxidative damage to these proteins may be one of the upstream events in the molecular pathway leading to excitotoxic cell death in KA-treated rat hippocampus, and these proteins may be targets of therapeutic intervention for seizure-induced neuronal death.


Subject(s)
Hippocampus/metabolism , Hippocampus/pathology , Neurotoxins/toxicity , Oxidative Stress/physiology , Proteomics/methods , Status Epilepticus/metabolism , Status Epilepticus/pathology , Acute Disease , Animals , Cell Death/physiology , Disease Models, Animal , Excitatory Amino Acid Agonists/toxicity , Kainic Acid/toxicity , Male , Nerve Tissue Proteins/metabolism , Neurons/metabolism , Neurons/pathology , Rats , Rats, Wistar
11.
Brain Res ; 1367: 22-32, 2011 Jan 07.
Article in English | MEDLINE | ID: mdl-20950588

ABSTRACT

Prostaglandin (PG) F(2α) is a product of cyclooxygenase (COX)-catalyzed metabolism of arachidonic acid and exerts biological functions in various tissues. Prostaglandin ethanolamide (prostamide) F(2α) is a COX-2-catalyzed metabolite of arachidonoyl ethanolamide (anandamide) that induces pharmacological actions in ocular tissues. Although PGF(2α) is one of the most abundant prostaglandins in the brain, function of PGF(2α) in the central nervous system (CNS) has not been extensively investigated. Recently identified prostamide/PGF synthase catalyzes the reductions of prostamide H2 to prostamide F(2α) and PGH2 to PGF(2α), chiefly in the CNS. We examined tissue distribution of the enzyme in the CNS by immunohistochemistry, double immunofluorescence, and immuno-electron microscopy. We confirmed histological findings by immunofluorescence analyses of brain cell cultures. Prostamide/PGF synthase was expressed preferentially in the white matter bundles of the entire CNS of adult mice with less marked expression in neuronal cell bodies. The enzyme was colocalized with myelin basic protein (MBP) in myelin sheaths but not in axons. At the ultrastructural level, the enzyme was localized to myelin sheaths. Expression of the enzyme increased between P9 and P14 during the postnatal development, presumably in accordance with myelinogenesis. Cultured oligodendrocytes at 7 days in vitro expressed the enzyme in cytoplasmic processes where the enzyme was colocalized with MBP. Immunoreactivity for COX-2 was detected in white matter and cultured oligodendrocytes. Relatively selective localization of prostamide/PGF synthase suggests that myelin sheaths of the CNS may serve as the sites for producing prostamide F(2α) and/or PGF(2α), which may contribute to the formation and maintenance of central myelin.


Subject(s)
Central Nervous System/cytology , Central Nervous System/growth & development , Dinoprost/metabolism , Gene Expression Regulation, Developmental/physiology , Hydroxyprostaglandin Dehydrogenases/metabolism , Myelin Sheath/metabolism , Age Factors , Animals , Cells, Cultured , Cyclooxygenase 2/metabolism , Mice , Mice, Inbred C57BL , Microscopy, Electron, Transmission/methods , Myelin Sheath/ultrastructure , Oligodendroglia/metabolism , Rats , Rats, Wistar
12.
Brain Behav Immun ; 25(1): 83-100, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20804842

ABSTRACT

Aging is a result of damage accumulation, and understanding of the mechanisms of aging requires exploration of the cellular and molecular systems functioning to control damage. Senescence-accelerated mouse prone 10 (SAMP10) has been established as an inbred strain exhibiting accelerated aging with an earlier onset of cognitive impairment due to neurodegeneration than the senescence-resistant control (SAMR1) strain. We hypothesized that tissue-protective responses of glial cells are impaired in SAMP10 mice. We injected kainic acid (KA) to induce hippocampal injury and studied how cytokines were upregulated on Day 3 using 3-month-old SAMP10 and SAMR1 mice. Following microarray-based screening for upregulated genes, we performed real-time RT-PCR and immunohistochemistry. Results indicated well-orchestrated cytokine-mediated glial interactions in the injured hippocampus of SAMR1 mice, in which microglia-derived interferon (IFN)-γ stimulated astrocytes via IFN-γ receptor and thereby induced expression of CXCL10 and macrophage inflammatory protein (MIP)-1α, and activated microglia produced granulocyte-macrophage colony-stimulating factor (GM-CSF) and osteopontin (OPN). OPN was the most strongly upregulated cytokine. CD44, an OPN receptor, was also strongly upregulated in the neuropil, especially on neurons and astrocytes. KA-induced hippocampal upregulation of these cytokines was strikingly reduced in SAMP10 mice compared to SAMR1 mice. On Day 30 after KA injection, SAMP10 but not SAMR1 mice exhibited hippocampal layer atrophy. Since the OPN-CD44 system is essential for neuroprotection and remodeling, these findings highlight the defects of SAMP10 mice in cytokine-mediated neuroprotective glia-neuron interactions, which may be associated with the mechanism underlying the vulnerability of SAMP10 mice to age-related neurodegeneration.


Subject(s)
Aging/genetics , Aging/physiology , Cytokines/physiology , Hippocampus/pathology , Neuroglia/physiology , Neurotoxins/toxicity , Animals , Astrocytes/physiology , Cell Size , Gene Expression/drug effects , Hyaluronan Receptors/immunology , Immunohistochemistry , Kainic Acid/toxicity , Mice , Mice, Neurologic Mutants , Microglia/immunology , Microglia/pathology , Neurons/physiology , Oligonucleotide Array Sequence Analysis , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction/physiology , Up-Regulation/genetics , Up-Regulation/physiology
13.
Neuropathology ; 31(1): 20-8, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20497341

ABSTRACT

The ageing brain is characterized by degenerative changes in both neurons and glia. Although neurons are known to lose dendritic complexity with ageing, age-related changes in the morphology of microglia have not been well documented. We investigated potential age-related changes in microglial morphology using mouse models. Senescence-accelerated mouse prone 10 (SAMP10) in which neuronal degeneration begins to appear around 8 months of age and becomes progressively remarkable with advancing age was used as a model of brain ageing. Senescence-accelerated mouse resistant 1 (SAMR1) in which age-related neuronal changes are inconspicuous was used as usual-ageing controls. Hippocampal sections prepared from 3-, 8- and 14-month-old SAMP10 and 3-, 8-, 14- and 24-month-old SAMR1 mice were stained immunohistochemically with anti-Iba-1 antibody to highlight microglia. Stick figures of individual microglia reflecting the length and complexity of cytoplasmic processes were made by camera lucida drawing. Parameters representing morphological features of microglia were quantified using an image analyzer: area of convex closure, cell body area, number of primary processes, maximal branch order, combined projection length, number of segments and number of tips. Pathological changes of processes such as beading and clusters of fragmented twigs were counted. In microglia of 3- and 8-month-old SAMP10 mice, combined projection length was shorter and numbers of segments and tips were smaller than those in age-matched SAMR1 mice. Similar changes were detected in SAMR1 mice at age 14 months and older. Microglia of SAMP10 mice at all ages were characterized by having frequent pathological changes in processes, which were not remarkable in SAMR1 mice at any age. These morphological abnormalities in microglia of SAMP10 mice preceded the onset of neuronal degeneration and may lead to making brain tissue less protective to neurons. We propose that preceding abnormalities in microglia may contribute to the vulnerability to age-related neuronal degeneration in SAMP10 mice.


Subject(s)
Aging/pathology , Hippocampus/pathology , Microglia/pathology , Nerve Degeneration/pathology , Neurons/pathology , Animals , Image Processing, Computer-Assisted , Immunohistochemistry , Mice , Mice, Mutant Strains
14.
Mech Ageing Dev ; 131(6): 379-88, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20471994

ABSTRACT

Senescence-accelerated mouse prone 10 (SAMP10) strain is a model of age-related neurodegeneration in the limbic forebrain. To investigate changes in protein expression profiles involved in neurodegeneration, we performed two-dimensional fluorescence difference gel electrophoresis and compared protein expression in the limbic and non-limbic forebrains of SAMP10 and control mice at various ages. Among protein spots in which patterns of aging in expression in the limbic forebrain differed between SAMP10 and control, we identified three proteins by mass spectrometry: pyridoxal phosphate phosphatase (PLPP), collapsin response mediator protein 2 (CRMP-2) and alpha-internexin. Expression of PLPP was increased in the limbic forebrain of 3-month-old SAMP10 mice. Levels of CRMP-2 and phosphorylated alpha-internexin were increased in the limbic forebrain of SAMP10 mice at age 8 months and remained high until 14 months. Western blot revealed elevation in the level of phosphorylated CRMP-2 and the ratio of phosphorylation of alpha-internexin. Immunohistochemistry revealed that alpha-internexin was chiefly distributed in axons. Aging in SAMP10 mice was associated with abnormality of PLPP, CRMP-2 and alpha-internexin, all of which are known to be involved in brain cytoskeleton formation and associated with acute and chronic neurodegenerative conditions. These proteins are promising targets for further investigation of the mechanisms underlying brain aging.


Subject(s)
Aging/metabolism , Limbic System/metabolism , Neurodegenerative Diseases/metabolism , Prosencephalon/metabolism , Aging/pathology , Animals , Disease Models, Animal , Intercellular Signaling Peptides and Proteins/analysis , Intercellular Signaling Peptides and Proteins/metabolism , Intermediate Filament Proteins/analysis , Intermediate Filament Proteins/metabolism , Limbic System/pathology , Male , Mice , Mice, Inbred Strains , Nerve Tissue Proteins/analysis , Nerve Tissue Proteins/metabolism , Neurodegenerative Diseases/pathology , Phosphoric Monoester Hydrolases/analysis , Phosphoric Monoester Hydrolases/metabolism , Prosencephalon/pathology , Proteomics
15.
Neurochem Res ; 34(4): 679-87, 2009 Apr.
Article in English | MEDLINE | ID: mdl-18688709

ABSTRACT

The SAM strain of mice is actually a group of related inbred strains consisting of a series of SAMP (accelerated senescence-prone) and SAMR (accelerated senescence-resistant) strains. Compared with the SAMR strains, the SAMP strains show a more accelerated senescence process, a shorter lifespan, and an earlier onset and more rapid progress of age-associated pathological phenotypes similar to human geriatric disorders. The higher oxidative stress status observed in SAMP mice is partly caused by mitochondrial dysfunction, and may be a cause of this senescence acceleration and age-dependent alterations in cell structure and function. Based on our recent observations, we discuss a possible mechanism for mitochondrial dysfunction resulting in the excessive production of reactive oxygen species, and a role for the hyperoxidative stress status in neurodegeneration in SAMP mice. These SAM strains can serve as a useful tool to understand the cellular mechanisms of age-dependent degeneration, and to develop clinical interventions.


Subject(s)
Aging/metabolism , Disease Models, Animal , Neurodegenerative Diseases/metabolism , Oxidative Stress , Animals , Humans , Inflammation/metabolism , Mice , Mice, Inbred Strains , Mitochondria/physiology , Neurodegenerative Diseases/immunology , Neurodegenerative Diseases/pathology , Reactive Oxygen Species/metabolism
16.
Neuropathology ; 28(5): 485-96, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18384512

ABSTRACT

The proteins that accumulate in pathologic lesions of neurodegenerative disorders are thought to be closely associated with neuronal cell damage. However, whether or not the formation of cytoplasmic or nuclear inclusions by expanded polyglutamine (polyQ) is directly toxic to neurons has been controversial to date. We prepared a culture model system in which polyQ tracts were transfected into Neuro2a, cells of neuronal origin, to study novel factors involved in cell toxicity of polyQ tracts to neuronal cells. Pathogenic polyQ tracts of 79 repeats (Q79C) when expressed in cytoplasm of Neuro2a cells changed in their intracellular distribution patterns from homogeneous, via punctate aggregates, to massive aggregates with incubation time. Some polyQ tracts formed nuclear inclusions. Cytoplasmic massive aggregates of Q79C tended to be associated with apoptotic fate of Neuro2a cells. Cells exhibiting cytoplasmic massive inclusions had the highest expression level of polyQ tracts among cells with four patterns of intracellular distribution. The elevation in the expression levels of polyQ tracts was not due to the difference in the initial transfection efficiency. When compared among cells expressing polyQ tracts at similar levels, damages were most remarkable in cells with cytoplasmic massive aggregate in terms of shrunken cellular and nuclear sizes. Cells with the other patterns of polyQ tract distribution such as cytoplasmic homogeneous, cytoplasmic punctate and nuclear inclusions were relatively spared. These data suggest that the severity of cell damages depends on the type of intracellular distribution of polyQ tracts, in addition to the expression level of polyQ tracts.


Subject(s)
Neurons/pathology , Peptides/toxicity , Trinucleotide Repeat Expansion , Apoptosis/physiology , Cell Nucleus/metabolism , Cell Nucleus/pathology , Cytoplasm/metabolism , Cytoplasm/pathology , Humans , Immunoblotting , Inclusion Bodies/metabolism , Inclusion Bodies/pathology , Intranuclear Inclusion Bodies/metabolism , Intranuclear Inclusion Bodies/pathology , Microscopy, Fluorescence , Transfection
17.
J Neurosci Res ; 86(6): 1316-23, 2008 May 01.
Article in English | MEDLINE | ID: mdl-18044762

ABSTRACT

The accelerated senescence-prone SAMP10 mouse strain is a model for age-dependent neurodegeneration and is characterized by brain atrophy and deficits in learning and memory. Because perineuronal nets play an important role in the synaptic plasticity of adult brains, we examined the distributions of molecules that constitute perineuronal nets in SAMP10 mouse brain samples and compared them with those in control SAMR1 mouse samples. Proteoglycan-related monoclonal antibody 6B4 (MAb6B4) clearly immunostained perineuronal nets in SAMR1 mice cortices, but the corresponding immunostaining in SAMP10 mice was very faint. MAb6B4 recognizes phosphacan/PTPzeta in immature brains. However, this antibody recognized several protein bands, including a 400-kDa core glycoprotein from chondroitin sulfate proteoglycan in homogenates of mature cortices from SAMR1 mice. The 400-kDa band was also recognized by antiaggrecan antibodies. The aggrecan core glycoprotein band was also detectable in samples from SAMP10 mice, but this glycoprotein was faintly immunostained by MAb6B4. Because MAb6B4 recognized the same set of protein bands that the monoclonal antibody Cat-315 recognized in mature cerebral cortices of SAMR1 mice, the MAb6B4 epitope appears to be closely related to that of Cat-315 and presumably represents a novel type of oligosaccharide that attaches to aggrecans. The Cat-315 epitope colocalized with aggrecan in perineuronal nets from SAMR1 mouse brain samples, whereas its expression was prominently reduced in SAMP10 mouse brain samples. The biological significance of the MAb6B4/Cat-315 epitope in brain function and its relationship to the neurodegeneration and learning disabilities observed in SAMP10 mice remain to be elucidated.


Subject(s)
Aggrecans/biosynthesis , Aggrecans/immunology , Aging/physiology , Antibodies, Monoclonal , Cerebral Cortex/metabolism , Nerve Net/metabolism , Aggrecans/chemistry , Animals , Blotting, Western , Chondroitin Sulfate Proteoglycans/chemistry , Chondroitin Sulfate Proteoglycans/immunology , Disease Models, Animal , Epitopes/biosynthesis , Epitopes/immunology , Immunohistochemistry , Mice , Mice, Inbred Strains , Nerve Degeneration , Receptor-Like Protein Tyrosine Phosphatases, Class 5/biosynthesis , Receptor-Like Protein Tyrosine Phosphatases, Class 5/chemistry , Receptor-Like Protein Tyrosine Phosphatases, Class 5/immunology
18.
Brain Res ; 1185: 75-85, 2007 Dec 14.
Article in English | MEDLINE | ID: mdl-17949696

ABSTRACT

The SAMP10 mouse strain is a model of brain aging in which senescence is characterized by cerebral atrophy and neurodegeneration phenotypes. To investigate the role of neuroinflammation in the age-associated neurodegeneration of SAMP10 mice, we assessed the expression of several cytokines and chemokines in the atrophy-prone brain region of SAMP10, and control, SAMR1 mice, which show a normal aging process. We also studied morphological changes in microglia with advancing age in atrophied regions. The expression of IL-1beta and IFN-gamma mRNA was about 2-fold greater in SAMP10 mice as compared to SAMR1 mice throughout their life span. The expression of IL-6 mRNA was 2.0-fold greater in SAMP10 mice as compared to SAMR1 mice at 14 months of age, although there was no difference at 3 months of age. Fourteen-month-old mice had a 2.1-fold greater expression of TNF-alpha mRNA than 3-month-old mice in both strains. The expression of MCP-1 mRNA was greater in SAMP10 mice than SAMR1 mice, and tended to increase with advancing age. Activated microglia were rarely observed in both strains at 3 months of age. At 14 months of age, however, SAMP10 mice had a 5.6-fold greater number of activated microglia than SAMR1 mice. The aforementioned results suggest the presence of a higher pro-inflammatory status in the atrophy-prone brain region of SAMP10 mice as compared to SAMR1 mice. Neuroinflammation is a possible mechanism of age-associated neurodegeneration in SAMP10 mice.


Subject(s)
Aging/metabolism , Cytokines/metabolism , Microglia/physiology , Neurodegenerative Diseases/metabolism , Neurodegenerative Diseases/pathology , Age Factors , Aging/genetics , Analysis of Variance , Animals , Brain/pathology , Cell Count , Cytokines/genetics , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay/methods , Mice , Mice, Inbred Strains , Neurodegenerative Diseases/genetics , Neurodegenerative Diseases/immunology , RNA, Messenger/metabolism
19.
J Neurosci Res ; 83(1): 110-8, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16299773

ABSTRACT

Neuroglycan C (NGC) is a transmembrane chondroitin sulfate proteoglycan with an EGF module. We studied the expression of NGC in the human brain, mainly in the hippocampus, and confirmed some observations by conducting experiments using rat brain. In humans, NGC mRNA was expressed exclusively in the brain, especially in the immature brain. The telencephalon, including the hippocampus and neocortex, showed strong mRNA expression. NGC was immunolocalized to neuropils in the hippocampus and neocortex of the adult rat. RT-PCR experiments showed that four splice variants (NGC-I, -II, -III, and -IV) were expressed in the adult human hippocampus. By Western blotting, the expression as proteins of all splice variants except NGC-II was confirmed in the adult rat hippocampus. NGC-IV, which was first found in the present study, had the shortest cytoplasmic domain among the four variants. NGC-IV mRNA was expressed by neurons, but not by astrocytes, in culture prepared from the fetal rat hippocampus, suggesting that NGC-IV plays a role specific to neurons. In addition, the human NGC gene, which is registered as CSPG5, comprised six exons and was approximately 19 kb in size. In exon 2, a single nucleotide polymorphism resulting in Val188Gly in the NGC ectodomain was observed.


Subject(s)
Brain Chemistry/genetics , Brain Chemistry/physiology , Chondroitin Sulfate Proteoglycans/genetics , Chondroitin Sulfate Proteoglycans/physiology , Chondroitin Sulfates/genetics , Chondroitin Sulfates/physiology , Neuregulins/genetics , Neuregulins/physiology , Proteoglycans/genetics , Proteoglycans/physiology , Amino Acid Sequence , Animals , Antibodies/chemistry , Antibodies/pharmacology , Astrocytes/drug effects , Astrocytes/metabolism , Blotting, Western , Cells, Cultured , DNA/biosynthesis , DNA/genetics , Exons/genetics , Gene Expression Regulation/genetics , Gene Expression Regulation/physiology , Hippocampus/cytology , Hippocampus/metabolism , Humans , Immunohistochemistry , Mice , Molecular Sequence Data , Rats , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Reverse Transcriptase Polymerase Chain Reaction , Species Specificity
20.
Eur J Neurosci ; 18(3): 563-70, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12911752

ABSTRACT

Platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) is a biologically active lipid mediator. We have previously shown the expression of PAF receptor in neurons and microglia. PAF is produced in the brain from its precursor, and degraded by the enzyme PAF acetylhydrolase. LIS1 is a regulatory subunit of PAF acetylhydrolase, and is identical to a gene whose deletion causes the human neuronal migration disorder, type I lissencephaly. Indeed, Lis1 mutant mice display defects in neuronal migration and layering in vivo, and also in cerebellar granule cell migration in vitro. However, the roles of PAF and the PAF receptor in the neuronal migration remain to be determined. Here, we show that PAF receptor-deficient mice exhibited histological abnormalities in the embryonic cerebellum. PAF receptor-deficient cerebellar granule neurons migrated more slowly in vitro than wild-type neurons, consistent with the observation that a PAF receptor antagonist reduced the migration of wild-type neurons in vitro. Synergistic reduction of neuronal migration was observed in a double mutant of PAF receptor and LIS1. Unexpectedly, PAF affected the migration of PAF receptor-deficient neurons, suggesting a receptor-independent pathway for PAF action. The PAF receptor-independent response to PAF was abolished in granule neurons derived from the double mutant mice. Thus, our results suggest that the migration of cerebellar granule cells is regulated by PAF through receptor-dependent and receptor-independent pathways, and that LIS1 is a pivotal molecule that links PAF action and neuronal cell migration both in vivo and in vitro.


Subject(s)
Microtubule-Associated Proteins/physiology , Neurons/physiology , Platelet Activating Factor/physiology , Receptors, G-Protein-Coupled , 1-Alkyl-2-acetylglycerophosphocholine Esterase , Animals , Cell Movement/physiology , Cerebellum/abnormalities , Cerebellum/cytology , Cerebellum/embryology , Congenital Abnormalities/physiopathology , Embryo, Mammalian/physiology , Mice , Mice, Knockout , Platelet Membrane Glycoproteins/physiology , Receptors, Cell Surface/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...